Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review (Q38359303)

2 September 2017

1 reference

title

Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review (English)

1 reference

2 September 2017

1 reference

1 reference

4

Gwenaël Le Moal

0 references

Estelle Cateau

object named as

Estelle Cateau

7

0 references

France Roblot

object named as

France Roblot

8

0 references

Cendrine Godet

1

object named as

Cendrine Godet

1 reference

2 September 2017

9

Jacques Cadranel

1 reference

2 September 2017

Véronique Goudet

2

1 reference

2 September 2017

François Laurent

3

1 reference

2 September 2017

Gwenaël Le Moal

4

1 reference

2 September 2017

Valérie Gounant

5

1 reference

2 September 2017

Jean-Pierre Frat

6

1 reference

2 September 2017

publication date

1 March 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

58

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

173-180

1 reference

Pulmonary aspergillosis: a clinical review

2 September 2017

cites work

1 reference

Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature

21 January 2018

1 reference

Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review

21 January 2018

1 reference

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

21 January 2018

1 reference

High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.

21 January 2018

1 reference

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

21 January 2018

1 reference

New methods of delivery of amphotericin B.

21 January 2018

1 reference

Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections

21 January 2018

1 reference

Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety

21 January 2018

1 reference

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.

21 January 2018

1 reference

Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter

21 January 2018

1 reference

Voriconazole : a review of its use in the management of invasive fungal infections

21 January 2018

1 reference

Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis

21 January 2018

1 reference

Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis

21 January 2018

1 reference

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

21 January 2018

1 reference

Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant

21 January 2018

1 reference

Dose tolerability of chronically inhaled voriconazole solution in rodents.

21 January 2018

1 reference

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

21 January 2018

1 reference

Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation

21 January 2018

1 reference

Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation

21 January 2018

1 reference

Prophylactic application of nebulized liposomal amphotericin B in hematologic patients with neutropenia.

21 January 2018

1 reference

Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: Figure 1–

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/MYC.12294

1 reference

2 September 2017

1 reference